Bernd Lamprecht

Head of Department

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bernd Lamprecht is the Head of Department at Kepler Universitätsklinikum GmbH in Austria. His research areas include chronic airflow obstruction, spirometric restriction, and the implications of lung function on cardiometabolic diseases, as evidenced by his recent publications. He has contributed significantly to studies surrounding bronchodilator responsiveness, COVID-19 biomarkers, and the characteristics of COPD in various populations.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Collaborators (8)

Joan B Soriano

Profesor Asociado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Soyoung Lee

Charité - Universitätsmedizin Berlin

GERMANY

View details

Andreas Horner

Johannes Kepler University Linz

AUSTRIA

View details

Theresa Mair

Johannes Kepler Universität Linz Technisch-Naturwissenschaftliche Fakultät

AUSTRIA

View details

Irene Tiemann-Boege

Associate Professor

Johannes Kepler University Linz

AUSTRIA

View details

Milo Puhan

Full Professor

University of Zurich

SWITZERLAND

View details

Helmut J.F. SALZER

Head of the Division of Infectious Diseases and Tropical Medicine

Universitätsklinikum Hamburg-Eppendorf

AUSTRIA

View details

Jakob Trimpert

Freie Universität Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bernd Lamprecht

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19

Concordance between FVC and FEV6 for identifying chronic airflow obstruction and spirometric restriction in the Burden of Obstructive Lung Disease (BOLD) study

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

sST2 is a key outcome biomarker in COVID-19

Bronchodilator responsiveness and future chronic airflow obstruction

Lung function and onset of cardiometabolic diseases in the longitudinal Burden of Obstructive Lung Disease study

Shall We Screen Lung Cancer with Volume Computed Tomography in Austria? A Cost-Effectiveness Modelling Study

Functional Improvement at One Year in Fibrotic Interstitial Lung Diseases—Prognostic Value of Baseline Biomarkers and Anti-Inflammatory Therapies

COPD in special populations- focus on younger and never-smoking patients from two Austrian real world studies

Characteristics of Preserved Ratio Impaired Spirometry (PRISm) patients in Austrian real world COPD studies

Discordant airways obstruction – subjects in between spirometric definitions of COPD – an analysis of the CLARA Studies

Statin use and its implications on survival and disease progression in the European MultiPartner Idiopathic Pulmonary Fibrosis Registry (EMPIRE)

The GOLD 2023 proposed taxonomy: a new tool to determine COPD etiotypes

Processing Hundreds of SARS-CoV-2 Samples with an In-House PCR-Based Method without Robotics

[COVID-19 Vaccination in Asthma Patients Treated with Biologicals - Statement of the Austrian Society of Pneumology and German Respiratory Society].

Collaborators (8)

Joan B Soriano

Soyoung Lee

Andreas Horner

Theresa Mair

Irene Tiemann-Boege

Milo Puhan

Helmut J.F. SALZER

Jakob Trimpert

Make your next move.